Synthetic lethality from the combination of a histone methyltransferase SUV39H2 inhibitor and a poly (ADP-ribose) polymerase inhibitor for uterine leiomyosarcoma.
Saved in:
| Title: | Synthetic lethality from the combination of a histone methyltransferase SUV39H2 inhibitor and a poly (ADP-ribose) polymerase inhibitor for uterine leiomyosarcoma. |
|---|---|
| Authors: | Toyohara Y; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.; Division of Cancer Epigenomics, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan., Sone K; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. ksone5274@gmail.com., Kumegawa K; Cancer Cell Diversity Project, NEXT-Ganken Program, Japanese Foundation for Cancer Research, Tokyo, Japan., Yamamoto Y; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Hachijo R; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.; Division of Cancer Epigenomics, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan., Kukita A; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Taguchi A; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Ikemura M; Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Miyamoto Y; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Tanikawa M; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Iriyama T; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Mori M; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Hamamoto R; Division of Medical AI Research and Development, National Cancer Center Research Institute, Tokyo, Japan.; Cancer Translational Research Team, RIKEN Center for Advanced Intelligence Project, Tokyo, Japan., Ushiku T; Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Oda K; Division of Integrative Genomics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Hirota Y; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Maruyama R; Division of Cancer Epigenomics, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.; Cancer Cell Diversity Project, NEXT-Ganken Program, Japanese Foundation for Cancer Research, Tokyo, Japan., Osuga Y; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. |
| Source: | BMC cancer [BMC Cancer] 2025 Dec 16; Vol. 25 (1), pp. 1873. Date of Electronic Publication: 2025 Dec 16. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41402789 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Synthetic lethality from the combination of a histone methyltransferase SUV39H2 inhibitor and a poly (ADP-ribose) polymerase inhibitor for uterine leiomyosarcoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Toyohara+Y%22">Toyohara Y</searchLink>; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.; Division of Cancer Epigenomics, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Sone+K%22">Sone K</searchLink>; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. ksone5274@gmail.com.<br /><searchLink fieldCode="AU" term="%22Kumegawa+K%22">Kumegawa K</searchLink>; Cancer Cell Diversity Project, NEXT-Ganken Program, Japanese Foundation for Cancer Research, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Yamamoto+Y%22">Yamamoto Y</searchLink>; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Hachijo+R%22">Hachijo R</searchLink>; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.; Division of Cancer Epigenomics, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Kukita+A%22">Kukita A</searchLink>; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Taguchi+A%22">Taguchi A</searchLink>; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Ikemura+M%22">Ikemura M</searchLink>; Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Miyamoto+Y%22">Miyamoto Y</searchLink>; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Tanikawa+M%22">Tanikawa M</searchLink>; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Iriyama+T%22">Iriyama T</searchLink>; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Mori+M%22">Mori M</searchLink>; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Hamamoto+R%22">Hamamoto R</searchLink>; Division of Medical AI Research and Development, National Cancer Center Research Institute, Tokyo, Japan.; Cancer Translational Research Team, RIKEN Center for Advanced Intelligence Project, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Ushiku+T%22">Ushiku T</searchLink>; Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Oda+K%22">Oda K</searchLink>; Division of Integrative Genomics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Hirota+Y%22">Hirota Y</searchLink>; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Maruyama+R%22">Maruyama R</searchLink>; Division of Cancer Epigenomics, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.; Cancer Cell Diversity Project, NEXT-Ganken Program, Japanese Foundation for Cancer Research, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Osuga+Y%22">Osuga Y</searchLink>; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100967800%22">BMC cancer</searchLink> [BMC Cancer] 2025 Dec 16; Vol. 25 (1), pp. 1873. <i>Date of Electronic Publication: </i>2025 Dec 16. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100967800 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1471-2407 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214712407%22">14712407 </searchLink><i>NLM ISO Abbreviation: </i>BMC Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41402789 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12885-025-15267-6 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1873 Titles: – TitleFull: Synthetic lethality from the combination of a histone methyltransferase SUV39H2 inhibitor and a poly (ADP-ribose) polymerase inhibitor for uterine leiomyosarcoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Toyohara Y – PersonEntity: Name: NameFull: Sone K – PersonEntity: Name: NameFull: Kumegawa K – PersonEntity: Name: NameFull: Yamamoto Y – PersonEntity: Name: NameFull: Hachijo R – PersonEntity: Name: NameFull: Kukita A – PersonEntity: Name: NameFull: Taguchi A – PersonEntity: Name: NameFull: Ikemura M – PersonEntity: Name: NameFull: Miyamoto Y – PersonEntity: Name: NameFull: Tanikawa M – PersonEntity: Name: NameFull: Iriyama T – PersonEntity: Name: NameFull: Mori M – PersonEntity: Name: NameFull: Hamamoto R – PersonEntity: Name: NameFull: Ushiku T – PersonEntity: Name: NameFull: Oda K – PersonEntity: Name: NameFull: Hirota Y – PersonEntity: Name: NameFull: Maruyama R – PersonEntity: Name: NameFull: Osuga Y IsPartOfRelationships: – BibEntity: Dates: – D: 16 M: 12 Text: 2025 Dec 16 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1471-2407 Numbering: – Type: volume Value: 25 – Type: issue Value: 1 Titles: – TitleFull: BMC cancer Type: main |
| ResultId | 1 |
